These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day. Daughton DM; Fortmann SP; Glover ED; Hatsukami DK; Heatley SA; Lichtenstein E; Repsher L; Millatmal T; Killen JD; Nowak RT; Ullrich F; Patil KD; Rennard SI Prev Med; 1999 Feb; 28(2):113-8. PubMed ID: 10048102 [TBL] [Abstract][Full Text] [Related]
7. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Perkins KA; Lerman C; Keenan J; Fonte C; Coddington S Nicotine Tob Res; 2004 Jun; 6(3):501-7. PubMed ID: 15203784 [TBL] [Abstract][Full Text] [Related]
8. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Zevin S; Jacob P; Benowitz NL Clin Pharmacol Ther; 1998 Jul; 64(1):87-95. PubMed ID: 9695723 [TBL] [Abstract][Full Text] [Related]
9. The effects of transdermal nicotine on inspection time. Thompson JC; Wilby G; Stough C Hum Psychopharmacol; 2002 Apr; 17(3):157-61. PubMed ID: 12404693 [TBL] [Abstract][Full Text] [Related]
10. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice. Henzl MR; Loomba PK J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327 [TBL] [Abstract][Full Text] [Related]
11. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study. Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530 [TBL] [Abstract][Full Text] [Related]
12. Influence of morning or evening administration on absorption of theophylline. Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep. Aubin HJ; Luthringer R; Demazières A; Dupont C; Lagrue G Nicotine Tob Res; 2006 Apr; 8(2):193-201. PubMed ID: 16766412 [TBL] [Abstract][Full Text] [Related]
14. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Lerman C; Tyndale R; Patterson F; Wileyto EP; Shields PG; Pinto A; Benowitz N Clin Pharmacol Ther; 2006 Jun; 79(6):600-8. PubMed ID: 16765148 [TBL] [Abstract][Full Text] [Related]
15. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch. Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833 [TBL] [Abstract][Full Text] [Related]
16. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal. Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080 [TBL] [Abstract][Full Text] [Related]
17. Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Benowitz NL; Zevin S; Jacob P J Pharmacol Exp Ther; 1998 Dec; 287(3):958-62. PubMed ID: 9864279 [TBL] [Abstract][Full Text] [Related]
18. Microprocessor-controlled iontophoretic drug delivery of 5-fluorouracil: pharmacodynamic and pharmacokinetic study. Chandrashekar NS; Shobha Rani RH J BUON; 2007; 12(4):529-34. PubMed ID: 18067212 [TBL] [Abstract][Full Text] [Related]
19. Case studies of three pregnant smokers and their use of nicotine replacement therapy. Hotham ED; Gilbert AL; Atkinson ER Midwifery; 2005 Sep; 21(3):224-32. PubMed ID: 15967546 [TBL] [Abstract][Full Text] [Related]